In the past few years, the APA association and many other organizations have made effective use in the presentation in the annual meetings so as to convey the research news to the members as well as attendees. Read more.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
NEW RESEARCH STUDIES ON TREATMENTS FOR BIPOLAR DISORDER
In the past few years, the APA association and many other organizations have made effective use in the
presentation in the annual meetings so as to convey the research news to the members as well as
attendees. The meeting, which was conducted this year, stood out. The poster sessions that were made
on different health conditions were rich in information and provided new study on the research.
There has been no psychotropic drug, which is approved by the FDA as the effectual medication in a
combined medication regimen for the treatment of psychiatric disorder. On the other hand, as per the
bipolar disorder research studies of New York City, psychiatrists often go for drug regimens so as to treat
the patients suffering from bipolar disorder. Professional advice on this practice has advanced in current
years to a place that is much more effectual for such use. This change took place as a function of
advanced evidence of the difficulty of illness that needs to be managed in bipolar disorder. In addition to
that, there is proof of factors that influence certain patients to be ineffective against lithium treatment.
The research proved that the only mood stabilizer, which is approved, for the effective treatment of
mania is Divalproex that appears to have a better and broader level of efficiency as compared to lithium,
although it is still ineffective for considerable number of people. Carbamazepine has proved out to be
ineffective but it is still effective on some people. Still, it has number of drawbacks like low tolerance,
which makes it particularly complicated to combine the medications due to its induction of 2A4 hepatic
oxidative enzymes, which metabolizes many kinds of drug.
Most of the people having bipolar disorder do not react to the drug lithium. The research also brings the
scientists closer to the understanding of the psychiatric illness that causes severe mood swings which
also includes emotional fluctuations. The depression research studies as made by the New York City
proves that the brain cells of the people suffering from bipolar disorder seem to be very sensitive more
than the brain cells of the people who do not have any mental illness. The researchers have also found
out that the brain cells from the patients going through bipolar disorder had much more active
mitochondria of the cells, which is referred as the powerhouse of the cell.
The discoveries can give you insights regarding the current treatment also. Lithium is used for the
treatment of bipolar disorder but as per the Headache Research studies New York City, not all the
patients actually react to the drug. The disorder affects more than 5 million people all around America;
this has been recently said by the news release.
As per the studies, three patients got benefit from lithium, while others remain ineffective. The neurons
of the three individual, which responded to lithium, became less sensitive when it was open to the drug
and the neurons from the people who were non-responders were highly sensitive when the lithium was
exposed to them.
ABOUT THE COMPANY
SPRI Clinical Trials of Brooklyn was Founded in 1970 the Social Psychiatry Research Institute "SPRI" is
one of the leading research facilities in the country. They conduct clinical trials, drug studies, drug
testing, drug trials all one in the same at our medical facility.